SC 13D

Company

BioNexus Gene Lab Corp

Filed

January 17, 2024

Accession Number

0001477932-24-000214

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →